[HTML][HTML] Prognostic and predictive biomarkers in gliomas

P Śledzińska, MG Bebyn, J Furtak… - International journal of …, 2021 - mdpi.com
Gliomas are the most common central nervous system tumors. New technologies, including
genetic research and advanced statistical methods, revolutionize the therapeutic approach …

[HTML][HTML] Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma

…, J Rakowska, M Harat, T Szylberg, J Furtak… - Nature …, 2023 - nature.com
Accurate determination of the extent and grade of adult-type diffuse gliomas is critical to
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …

[HTML][HTML] New chemical biopsy tool for spatially resolved profiling of human brain tissue in vivo

…, K Łuczykowski, K Jaroch, M Birski, J Furtak… - Scientific Reports, 2021 - nature.com
It is extremely challenging to perform chemical analyses of the brain, particularly in humans,
due to the restricted access to this organ. Imaging techniques are the primary approach …

[HTML][HTML] MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study

…, M Birski, M Harat, R Włodarski, J Furtak - Biomedicines, 2022 - mdpi.com
Glioblastoma is the most malignant central nervous system tumor, which represents 50% of
all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment …

Quality of YouTube videos on meningioma treatment using the DISCERN instrument

P Śledzińska, MG Bebyn, J Furtak - World Neurosurgery, 2021 - Elsevier
Objective To assess the quality of YouTube videos on meningioma treatment. Methods A
search was performed on YouTube using the keywords “meningioma treatment,” “meningeal …

[HTML][HTML] Glioma 2021 WHO classification: the superiority of NGS over IHC in routine diagnostics

P Śledzińska, M Bebyn, E Szczerba, J Furtak… - Molecular Diagnosis & …, 2022 - Springer
Introduction The accurate detection of genetic variants such as single substitutions (IDH1/2,
TERT), chromosomal abnormalities (CDKN2A, 1p/19q deletions, and EGFR amplifications), …

Motor cortex stimulation in patients with chronic central pain.

P Sokal, M Harat, P Zieliński, J Furtak… - Advances in clinical …, 2015 - europepmc.org
Motor cortex stimulation in patients with chronic central pain. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

[HTML][HTML] Investigating the potential use of chemical biopsy devices to characterize brain tumor lipidomes

…, K Jaroch, K Goryński, M Birski, J Furtak… - International Journal of …, 2022 - mdpi.com
The development of a fast and accurate intraoperative method that enables the differentiation
and stratification of cancerous lesions is still a challenging problem in laboratory medicine. …

[HTML][HTML] Metabolomic phenotyping of gliomas: what can we get with simplified protocol for intact tissue analysis?

…, K Goryński, K Jaroch, D Paczkowski, J Furtak… - Cancers, 2022 - mdpi.com
Simple Summary The diagnostic protocol for gliomas is based on histological examination
and the determination of genetic biomarkers. However, examining molecular biomarkers in …

[HTML][HTML] An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients

MA Lewandowska, J Furtak, T Szylberg… - Molecular diagnosis & …, 2014 - Springer
Background and Objective IDH1 (isocitrate dehydrogenase 1) is a potential biomarker and
drug target. Genomic and epigenetic data on astrocytoma have demonstrated that the IDH1 …